CompletedEarly Phase 1NCT04958486

Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa Ependymoma

Studying Ependymoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The University of Texas Health Science Center, Houston
Principal Investigator
David I Sandberg, MD
The University of Texas Health Science Center, Houston
Intervention
5-Azacytidine and trastuzumab infusion(drug)
Enrollment
4 enrolled
Eligibility
1-80 years · All sexes
Timeline
20212023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04958486 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma

← Back to all trials